NECTAR LIFESCIENCE chart

Last update: 2022-06-03
Key statistics and financials
Revenue per share 69.02
Dividend & YieldN/A₹ (N/A)
Beta 0.67
Market capitalization 5.7B
Operating cash flow N/A
ESG Scores unknown

Company description

Nectar Lifesciences Limited manufactures and sells pharmaceutical products in India and internationally. The company offers contract research and manufacturing services, including process development and optimization, process scale up and validation, preparation and international submission of drug master files and certificates of suitability, multi kilo pilot plant production, bulk production, and chiral resolution; and chemical and analytical development, as well as analytical, manufacturing, and engineering consulting services. Its active pharmaceutical ingredients and intermediates comprise cefixime trihydrate, cefuroxime axetil, cefpodoxime proxetil, cefdinir, ceftriaxone sodium, cefotaxime sodium, cefuroxime sodium, ceftazidime, cefepime HCl, cephalothin, cefazolin sodium, cefprozil, cefoperzone sodium, cefpirome sulphate, and cefoxitin sodium. The company also offers contract manufacturing for finished dosage forms, such as tablets, capsules, dry powder oral suspensions, and granules and injectable for cephalosporins. In addition, it provides a range of diagnostics products; empty hard gelatin capsules; and menthol products. Nectar Lifesciences Limited was incorporated in 1995 and is headquartered in Chandigarh, India.

Sector: Healthcare - Industry: Drug Manufacturers—Specialty & Generic

Financial Ratios
Quick Ratio0.49
Working Capital-1.42
Return On Equity-0.07
Debt To Equity0.12
Fixed Asset Ratio0.03
Fixed Interest Cover0.58

Financial data

Financial Statements

Cashflow Statement 2018-03-31 2019-03-31 2020-03-31 2021-03-31
Change To Liabilities
Total Cashflows From Investing Activities -294.35M -261.3M -331.27M -286.24M
Net Borrowings 769.49M -516.03M -1.25B 1.25B
Total Cash From Financing Activities -396.02M -2.01B -2.52B 114.9M
Change To Operating Activities -1.61B -131.93M 703.6M -405.42M
Issuance Of Stock
Net Income 522.72M 476M 317.89M -732.64M
Change In Cash -38.7M 120.16M -340k 42.45M
Effect Of Exchange Rate
Total Cash From Operating Activities 651.67M 2.39B 2.85B 213.79M
Depreciation 643.09M 632.57M 607.66M 602.53M
Change To Account Receivables
Other Cashflows From Financing Activities -1.15B -1.48B -1.26B -1.12B
Change To Netincome 1.09B 1.42B 1.22B 749.32M
Capital Expenditures -331.63M -381.27M -547.69M -312.41M

Income Statement 2018-03-31 2019-03-31 2020-03-31 2021-03-31
Research Development
Income Before Tax 626.83M 588.2M 374.71M -847.68M
Net Income 522.72M 476M 317.89M -732.64M
Selling General Administrative 797.97M 812.05M 828.16M 751.53M
Gross Profit 5.09B 5.65B 5.08B 3.86B
Ebit 1.72B 2.01B 1.59B 499.91M
Operating Income 1.72B 2.01B 1.59B 499.91M
Interest Expense -883.67M -878.23M -918.07M -857.65M
Income Tax Expense 104.11M 112.2M 56.82M -115.04M
Total Revenue 18.76B 27.83B 23.66B 15.43B
Cost Of Revenue 13.67B 22.18B 18.59B 11.57B
Total Other Income ExpenseNet -1.1B -1.42B -1.22B -1.35B
Net Income From Continuing Ops 522.72M 476M 317.89M -732.64M
Net Income Applicable To Common Shares 522.72M 476M 317.89M -732.64M

Balance Sheet Statement 2018-03-31 2019-03-31 2020-03-31 2021-03-31
Total Liabilities 16.65B 16B 14.97B 14.09B
Total Stockholder Equity 10.59B 11.05B 11.36B 10.62B
Other Current Liabilities 230.28M 664.48M 529.43M 556.54M
Total Assets 27.24B 27.05B 26.33B 24.71B
Common Stock 224.26M 224.26M 224.26M 224.26M
Other Current Assets 1.33B 1.11B 1.28B 1.36B
Retained Earnings 7.07B 7.54B 7.85B 7.11B
Treasury Stock
Cash 93.11M 213.27M 212.94M 255.39M
Total Current Liabilities 13.09B 13B 12.48B 11.87B
Other Stockholder Equity
Property, Plant, and Equipment 9.06B 8.85B 8.61B 8.32B
Total Current Assets 16.61B 16.69B 16.15B 12.39B
Net Tangible Assets 10.13B 10.66B 10.97B 10.24B
Net Receivables 6.58B 6.18B 4.58B 4.22B
Accounts Payable 5.39B 4.84B 5.27B 3.42B


Insider Transactions

Here are the insider transactions of stock shares related to NECTAR LIFESCIENCE:

Filer Name Transaction Text Ownership Date Filer Relation Shares
Goyal (Aryan)I2019-07-26Director (Executive)
Goyal (Sanjiv)D2019-07-24Executive Chairman16.72M
Goyal (Aryan)D2019-07-24Director (Executive)290k
Goyal (Saurabh)D2019-07-24Promoter243k
Sanjiv HUFD2019-07-24Promoter243k
Goyal (Sanjiv)D2017-03-28Executive Chairman21.22M
Sanjiv HUFD2017-03-28Promoter42.81M
Goyal (Raman)D2017-03-28Promoter21.58M
Kapur (Raman)D2010-03-22Director64.68k
Kapur (Raman)D2010-03-19Director517.86k
Kapur (Raman)D2010-03-16Director1.1k
Kapur (Raman)D2010-03-15Director351.33k
Kapur (Raman)D2010-03-10Director36.31k
Kapur (Raman)D2010-02-26Director28.73k

Insider transaction explanations

Insider buying is the legal purchase of shares by a senior executive or director of a company. "Filer Name" corresponds to the name of the stock buyer or seller. "Transaction Text" describes the transaction. "Ownership" gives information about the transaction type. "Date" is the reported transaction date. "Filer Relation" gives the role of the insider in the company. "Shares" is the value of the transaction. You will find the complete description of the General Transaction Codes on the SEC dedicated page


Investment strategy backtesting

These are the result of three automatic investment systems applied to NECTAR LIFESCIENCE. You will find the performance of an systematic investment system, a momentum strategy, and a buy the dip trading strategy.


Systematic investment results on NECTAR LIFESCIENCE

Here is the result of two systematic investment strategies applied to NECTAR LIFESCIENCE. The first strategy automatically buys the first day of the month, and the second strategy buys the fifteenth day of the month.

Systematic investment equity curve on NECTAR LIFESCIENCE

The following chart shows the equity curve of the two systematic investment strategies applied to NECTAR LIFESCIENCE:

NECTAR LIFESCIENCE automated entries

The systematic investment strategy that buys the first day of the month would give a performance of 41.96% on the backtest period.

Performance at glance

Performance

41.96 %

Latent gain

1052.85 ₹

Invested capital

2509.15 ₹

Annualized return

9.99 %
Build your Trading System
Automated Trading using Prorealtime ebook

Momentum strategy results on NECTAR LIFESCIENCE

This is the result of two momentum investment strategies applied to NECTAR LIFESCIENCE. The first strategy uses a momentum signal calculated on one quarter, and the second uses a momentum signal calculated on two quarters.

Momentum entry openings on NECTAR LIFESCIENCE

The following chart shows all the entries opened by the momentum investment system on NECTAR LIFESCIENCE:

NECTAR LIFESCIENCE momentum entries
  • The first momentum investment strategy would give 52.16% of return on NECTAR LIFESCIENCE. That represents 2477.85₹ of latent gain with 4750.15₹ of employed capital.
  • The second momentum investment strategy would give 61.8% of return on NECTAR LIFESCIENCE. That represents 2323.8₹ of latent gain with 3760.2₹ of employed capital.
Performance at glance (1Q Momentum)

Performance

52.16 %

Latent gain

2477.85 ₹

Invested capital

4750.15 ₹

Annualized return

16.19 %
Performance at glance (2Q Momentum)

Performance

61.8 %

Latent gain

2323.8 ₹

Invested capital

3760.2 ₹

Annualized return

16.61 %

Momentum equity curve on NECTAR LIFESCIENCE

The following chart shows the equity curve of the two momentum strategies applied to NECTAR LIFESCIENCE:

NECTAR LIFESCIENCE momentum equity

Note: the dividends potentially given by NECTAR LIFESCIENCE are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on NECTAR LIFESCIENCE

The following chart shows the employed capital evolution of the two momentum strategies on NECTAR LIFESCIENCE since the beginning:

NECTAR LIFESCIENCE

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250₹, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000₹.


Buy the dip strategy result on NECTAR LIFESCIENCE

Buy the dip entry openings on NECTAR LIFESCIENCE

NECTAR LIFESCIENCE

The performance achieved by the robo-advisor on NECTAR LIFESCIENCE is 35.61%. That represents 266.25$ of latent gain with 747.75₹ of employed capital. The following chart shows NECTAR LIFESCIENCE stock price with all the entries opened by the automated investment system.

Note: The blue line represents the weekly stock price of NECTAR LIFESCIENCE, and the green triangles represent the entry openings. The artificall robo-advisor needs at least 100 weeks of trading history to work.

Performance at glance

Performance

35.61 %

Latent gain

266.25 ₹

Invested capital

747.75 ₹

Annualized return

16.19 %

Equity curve of the strategy applied to NECTAR LIFESCIENCE

The following chart shows the result of the investment strategy applied to NECTAR LIFESCIENCE:

NECTAR LIFESCIENCE

Note: the dividends potentially given by NECTAR LIFESCIENCE are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on NECTAR LIFESCIENCE

The following chart shows the employed capital evolution since the beginning of the investment strategy on NECTAR LIFESCIENCE:

NECTAR LIFESCIENCE

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Investment strategies comparison on NECTAR LIFESCIENCE

In this section, I will compare the three previous investment strategies applied to NECTAR LIFESCIENCE.

Equity curve comparison on NECTAR LIFESCIENCE

The following chart shows the equity curve of the artificall advisor, the trend folowing and the automatic investment strategies:

NECTAR LIFESCIENCE investment strategy comparison

Employed capital comparison on NECTAR LIFESCIENCE

NECTAR LIFESCIENCE investment comparison

Performance comparison on NECTAR LIFESCIENCE

Strategy Latent Profit Growth Employed capital CAGR
Automatic investment 41.96% 1052.85₹ 2509.15₹ 9.99%
Momentum 1 quarter 52.16% 2477.85₹ 4750.15₹ 13.17%
Momentum 2 quarters 61.8% 2323.8₹ 3760.2₹ 16.61%
Non-directional 35.61% 266.25₹ 747.75₹ 16.19%
Annualized return comparison

Automatic investment

9.99 %

Momentum 1Q

16.61 %

Momentum 2Q

16.61 %

Non-directional

16.19 %

Correlated stocks

Here are the most positively and negatively correlated stocks with NECTAR LIFESCIENCE:

Positive correlations

Most correlated stocks this year


Most correlated stocks last 3 months

Negative correlation

Most negatively correlated stocks this year


Most negatively correlated stocks last 3 months

Note: The algorithm computes the probability of correlation between NECTAR LIFESCIENCE and the other stocks. There may be false positives or some missing correlated stocks. If the price of NECTAR LIFESCIENCE does not vary for 36 weeks, the correlation calculation result will be wrong.


Company information

Company name NECTAR LIFESCIENCE
Country India
City Chandigarh
Address SCO 38-39
Phone 91 17 2304 7777
Website www.neclife.com
FullTime employees 1693
Industry Drug Manufacturers—Specialty & Generic
Sector Healthcare
Exchange XNSE
Ticker NECLIFE.XNSE
Market

NECTAR LIFESCIENCE ESG Scores

Environment scores

Environment ESG Factors Scores
Environment Score 0
Peer Environment Performance unknown
Environment Percentile unknown
Palm Oil unknown
Nuclear unknown
Fur Leather unknown
GMO unknown
Coal unknown
Pesticides unknown
Animal Testing unknown

Social scores

Social ESG Factors Scores
Social Score 0
Peer Social Performance unknown
Social Percentile unknown
Highest Controversy unknown
Peer Highest Controversy Performance unknown
Adult unknown
Gambling unknown
Alcoholic unknown
Tobacco unknown
Catholic unknown
Controversial Weapons unknown
Small Arms unknown
Military Contract unknown
Peer Count unknown

Related Controversy:


Governance scores

Governance ESG Factors Scores
Governance Score 0
Peer Governance Performance unknown
Governance Percentile unknown

ESG at glance
Total ESG Scores: unknown
Environment Score: 0
Social Score: 0
Governance Score: 0

ESG Performance: unknown

Peer Group: unknown

Peer Esg Score Performance: unknown

Rating Year: unknown

Rating Month: unknown

Max Age: unknown

Percentile: unknown